Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × EC regimen × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Recruiting 3 Unknown 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 200 Nivolumab 153 Carboplatin 129 Specimen Handling 127 Magnetic Resonance Spectroscopy 112 Cyclophosphamide 109 Paclitaxel 103 Cisplatin 96 Biopsy 95 Radiotherapy 92 durvalumab 85 Dexamethasone 81 atezolizumab 77 Gemcitabine 69 Ipilimumab 68 Rituximab 58 Doxorubicin 58 Lenalidomide 57 Fluorouracil 55 Docetaxel 55 olaparib 53 Oxaliplatin 53 Capecitabine 52 Bevacizumab 52 Etoposide 49 Radiosurgery 46 Radiation 46 Taxes 44 Prednisone 44 Leucovorin 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609047 2024-01-24

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡